Three times of uncertainty involving false statements in Waigaoqiao plan
Source: Internet
Author: User
KeywordsEquity Taizhou the company
August 30, Waigaoqiao issued a fixed increase announcement, after the share price 11 trading board, or 211%. However, reporters in the south found that the company's huge 2.7 billion-dollar plan is variable. Its former subsidiary, Shanghai King and Health Industry Development Co., Ltd. (hereinafter referred to as "King and") investment in Taizhou Waigaoqiao Unicom pharmaceutical Company (hereinafter referred to as "Taizhou Company") two secured loans in September overdue, there is the possibility of triggering a lawsuit, which in turn will affect the approval of its refinancing, with details not seen in its announcements and earnings reports. Gujiai, a representative of the Waigaoqiao securities business, told reporters yesterday that the details of the matter, the company does not have detailed announcements; the impact on refinancing, the company is also in the evaluation, the current company in the emergency research program. Wang Zhibin, director of securities at Shanghai Jie law firm, said that Taizhou was on the verge of bankruptcy when it bought the King and Company in 2006, while Waigaoqiao described it as a premium asset and was suspected of misleading statements. An analyst who was not able to be named said the company rose by more than 300% per cent from the August 30 recovery to September 25, which would not have been as high if such information had been announced before the rally. The increase of the scheme is very popular in the market August 30, Waigaoqiao proposed to not more than 10 specific investors issued shares raise not more than 2.7 billion yuan, to invest in the Shanghai FTA Phase I construction projects and replenishment of the company's liquidity. Guangdong an unnamed analyst said that the project's internal rate of return of 10.1%, static investment recovery period of 7.58 years, the project economic benefits, and the amount of investment is huge, listed companies can be said to be very fancy to the company's follow-up development; October 1, the company's seventh session of the Board of Directors of the 23rd meeting smoothly through the directional issue of additional proposals. South reporters found that the meeting also considered another bill, said "according to our company and the agreement signed with the company, the resumption of the king and the company's equity, authorized the general manager in the 50 million yuan, the legal compliance to properly deal with the king and the company related debt matters, and will report the results to the board." The analyst said that this seemingly obscure bill is an understatement, in fact, it is directly related to the increase. Investment scene and direct loss 24 million South all reporters to get the conference materials Show: King and the company was founded in 2001, registered capital of 50 million yuan, mainly engaged in medical and pharmaceutical investment. 2003 Waigaoqiao deputy General Manager, King and company general manager Zhong Chunming misappropriation King and company funds, through the trust method to buy the king and 82% of the company's equity agreement. In August 2005, Zhong Chunming was sentenced for misappropriation of funds to acquire equity. In January 2006, Waigaoqiao recovered Zhong Chunming's 82% per cent stake in the company (total holding its 100% per cent stake). June 2011, Waigaoqiao and Shanghai Krupp Industrial Co., Ltd. signed an agreement to buy the king and the company's shares, but due to land issues, delayed until July 2012 to sign the transfer of equity contracts. March 2012, August 2012, the company for Taizhou company to advance a total of funds 150 for repayment, the company provides collateral for the unconditional return of the scene and the company's equity. The nine motion proposed by the Board of Directors of the company on October 1 this year is aimed at preventing the involvement of companies and senior executives in security lawsuits at this time. Gujiai, a representative of the Waigaoqiao securities business, said yesterday that the company was still evaluating the impact of the refinancing. The analyst said that the end of 2005 and the company has secured 65 million of the amount of the 2006 Waigaoqiao to 49 million yuan acquisition, this price is not very reasonable; in 2012, Waigaoqiao will be the King and equity transfer to the Shanghai Krupp, received the transfer of 40.64 million, but pay profit and loss of 14.96 million, is equivalent to Waigaoqiao recycling of about 25 million, so that the elimination of opportunity loss, 6 years Waigaoqiao This investment loss of 24 million yuan. At least three cases involving false statements in Waigaoqiao's announcements and earnings reports, the South reporters did not find the scene and the company and Taizhou company involved in security and litigation statements. Gujiai also said the details of the matter did not make a detailed announcement. "Waigaoqiao at least three times involving false statements," Wang Zhibin said, the first, 2012 equity transfer, due to the transfer of the consolidated statement of the subsidiary, its investment profit and loss and details should be done timely and complete disclosure. The second is the 2006 acquisition of the scene and the announcement. He said that Waigaoqiao concealed the capital chain of Taizhou Company is on the verge of breakage, and has actually discontinued the fact that the King and Taizhou company is the expression of high-quality assets, seriously misleading investors, suspected to constitute a false statement. January 11, 2006, Waigaoqiao Bulletin said, the acquisition of the scene and the company completed the project, the company will hold the Shanghai King and 100% Equity, into the year's consolidated report range. Shanghai Jing and the current major investment projects for Taizhou Waigaoqiao Unicom Pharmaceutical Industry, owns 59.5% of the company's stake, and Taizhou Pharmaceutical main products for more than 30 varieties of ciprofloxacin, such as the main raw materials of antibiotic drugs, some products in the market to obtain a monopoly, the company is expected to sell revenue in 05 will be more than 120 million yuan. Waigaoqiao said the above business will bring new growth to the company. At the seventh session of the Board of Directors of the 23rd meeting materials, Waigaoqiao to King and Taizhou company is another description: As of November 30, 2005, King and the company for Taizhou to provide the highest credit guarantee 65 million yuan. 2004, Taizhou company did not obtain any funds compensation, the demolition of the plant and production equipment, normal operation was seriously affected, in addition to the normal interest payments to ensure that the enterprise capital chain, Taizhou company suspected of the financial chain fracture distress situation. "The third lawsuit is this year," says Wang Zhibin, who is expected to sue Taizhou, King and Company and listed companies after the debt expires in September 2013, with the possibility of lawsuits and a series of disputes involving listed companies. For this risk, the listed company should disclose in time, not disclosed, also constitutes a false statement.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.